about
The benefits and risks of testosterone replacement therapy: a reviewPsychological stress and fibromyalgia: a review of the evidence suggesting a neuroendocrine linkStructural characterization of the human androgen receptor ligand-binding domain complexed with EM5744, a rationally designed steroidal ligand bearing a bulky chain directed toward helix 12Gynaecomastia--pathophysiology, diagnosis and treatmentTestosterone replacement therapy: current trends and future directionsAndropause. Testosterone replacement therapy for aging menTestosterone and vascular function in agingEnhanced transdermal bioavailability of testosterone propionate via surfactant-modified ethosomes.Testosterone ethosomes for enhanced transdermal delivery.Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Minireview: Nuclear receptors, hematopoiesis, and stem cells.Sex playing with the mind. Effects of oestrogen and testosterone on mood and cognition.Testosterone therapy in men: clinical and pharmacological perspectives.Diagnosis and treatment of Klinefelter syndrome.A practical guide to male hypogonadism in the primary care setting.Development and evaluation of formulations of microbial biotransformed extract of tobacco leaves for hair growth potential.Clinical evaluation and management of metabolic and morphologic abnormalities associated with human immunodeficiency virus.Designer steroids - over-the-counter supplements and their androgenic component: review of an increasing problem.Endocrinology of the aging male.Recent advances in the development of selective androgen receptor modulators.Analysis of 19-nortestosterone residue in animal tissues by ion-trap gas chromatography-tandem mass spectrometry.Testosterone deficiency and mood in aging men: pathogenic and therapeutic interactions.Androgen replacement therapy in the hypogonadal ageing man.Treatment of hypogonadal adolescent boys with long acting subcutaneous testosterone pelletsDiagnosis and treatment of sexual dysfunctions in late-onset hypogonadismCurrent concepts in anabolic-androgenic steroids.Hormone replacement therapy in hypopituitarism.Update on the male hormonal contraceptive agents.Risks of testosterone replacement therapy in ageing men.Pharmaceutical development and clinical effectiveness of a novel gel technology for transdermal drug delivery.Emerging drugs for hypogonadism.Minireview: Androgen metabolism in castration-resistant prostate cancer.The latest options and future agents for treating male hypogonadism.Testosterone and cardiovascular disease in men.Low-dose testosterone treatment decreases oxidative damage in TM3 Leydig cells.Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.Medical issues associated with anabolic steroid use: are they exaggerated?Enhanced evaluation of selective androgen receptor modulators in vivo.Therapeutic options for postmenopausal female sexual dysfunction.Protective effects of physiological testosterone on advanced glycation end product‑induced injury in human endothelial cells.
P2860
Q24658011-01794ADE-EED9-4746-B42B-DEA3BBC5073CQ24801007-C717D484-9D1F-4F0B-A450-4F709E30C34DQ27647445-53FF13E5-6FE4-4027-B2C2-ADA43C2A7750Q28245725-76BC8DEE-0AEE-4C71-AC09-56AF9F16252DQ28275913-4296C612-3AB1-4F10-8CD8-5752AE30450CQ28352150-AAC5068A-2DD9-4BE9-9377-481A48078D70Q28383213-7F8592B9-1BB9-46EC-8FF6-01839F45B473Q31128922-C430F34C-66A1-43A7-A9B2-21824BF2FED2Q33224076-93D8C64B-CD79-4DD6-BD0D-6A19BCAC129FQ33569169-B6DF27C3-1FEA-4F01-818E-BCE11616592FQ33576478-15803067-9643-45D4-9599-15F36EE7410AQ33833486-0099D6D3-1F81-4636-AD1D-A2034445692BQ33913912-3C62144D-D903-44E4-8BFC-F58DD8F2D87DQ33972816-7747571D-DCCE-4022-992E-DCDD18A40A9CQ34167760-003B0BC5-3319-44BE-8174-8EDE21AB9937Q34185691-49B78BBC-EDA8-4690-907B-664FB758C361Q34461377-5B743D33-6FCF-4858-BAEB-ACEF433AB70DQ34462912-013C0B33-717C-40CC-84AD-7F3264300160Q34777308-3164C1C9-203D-426D-AB6A-90802A7CDE5EQ34985529-0C2554FF-F698-4A27-A460-8021B27ED64FQ35028090-2D0F6493-8B96-4CFC-A099-5F8257E36EDCQ35064997-16DC2736-159E-4DC8-ABB0-02DAB29D444CQ35143954-A75149E3-EC8D-4F5C-8766-C133781A9A3DQ35255738-DBC43097-151A-456E-AFD5-1D5CAAD11EA0Q35624509-88A44CBE-B4B9-435D-8E2F-8A41611CD5B6Q35672930-E8A13DCF-DFD2-4945-B93B-DF4A7A52E5EDQ35779177-0BF40AAB-7049-4D21-87A1-B483C6F7A65EQ35871918-DD9543AB-D762-4958-ABE9-403AAF2F6B77Q35925655-DE938389-31CD-4B12-94F9-6D89B9197EE5Q36316846-5F98D17A-EFD3-46A1-AA31-BBA30E1CA479Q36634275-E8934D97-FCDF-443D-96D7-284E31DD8CD8Q36789277-BF4956D3-83FA-4F80-8B3A-2E41A24EF9EBQ37000744-4B515655-EBB7-4832-AEAB-96D64B9C46CCQ37037827-37FDFD6C-9EEA-4B0D-9005-7E4477074CBAQ37084626-DC0A65DA-4D76-43CD-BC17-418CAD2A184BQ37236103-046ED2E2-6A15-46B4-84DD-1DA0A0A6B71FQ37307083-DA1C62EA-C662-4441-9AAD-0A555E3A419DQ37543114-2678CFBF-5CAC-4BFA-94FE-6FCFAFB9DBC8Q37643712-B4453CC3-FF5E-4FDF-BA47-058AAB44BE1BQ37722123-DE89A939-0362-4011-A925-EA3544819A7D
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Androgens in men--uses and abuses.
@en
type
label
Androgens in men--uses and abuses.
@en
prefLabel
Androgens in men--uses and abuses.
@en
P1476
Androgens in men--uses and abuses.
@en
P2093
Bagatell CJ
Bremner WJ
P304
P356
10.1056/NEJM199603143341107
P407
P577
1996-03-01T00:00:00Z